Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All exercise studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchExerciseExercise (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Case 47% Improvement Relative Risk Exercise for COVID-19  Lin et al.  Prophylaxis Does physical activity reduce risk for COVID-19? Prospective study in multiple countries (March - October 2020) Fewer cases with higher activity levels (not stat. sig., p=0.4) c19early.org Lin et al., BMJ Open, September 2021 Favors exercise Favors inactivity

Predictors of incident SARS-CoV-2 infections in an international prospective cohort study

Lin et al., BMJ Open, doi:10.1136/bmjopen-2021-052025
Sep 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Exercise for COVID-19
9th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 66 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,900+ studies for 60+ treatments. c19early.org
Prospective survey analysis of 28,575 people in 99 countries, showing a lower risk of COVID-19 with a exercise, without statistical significance.
risk of case, 47.4% lower, OR 0.53, p = 0.40, inverted to make OR<1 favor high activity levels, exercise ≥1/month vs. exercise <1/month, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Lin et al., 21 Sep 2021, prospective, multiple countries, peer-reviewed, survey, 19 authors, study period 26 March, 2020 - 8 October, 2020.
This PaperExerciseAll
Predictors of incident SARS-CoV-2 infections in an international prospective cohort study
Anthony Lin, Eric Vittinghoff, Jeffrey Olgin, Noah Peyser, Sidney Aung, Sean Joyce, Vivian Yang, Janet Hwang, Robert Avram, Gregory Nah, Geoffrey H Tison, Alexis Beatty, Ryan Runge, David Wen, Xochitl Butcher, Cathy Horner, Helena Eitel, Mark Pletcher, Dr Gregory M Marcus
BMJ Open, doi:10.1136/bmjopen-2021-052025
Objective Until effective treatments and vaccines are made readily and widely available, preventative behavioural health measures will be central to the SARS-CoV-2 public health response. While current recommendations are grounded in general infectious disease prevention practices, it is still not entirely understood which particular behaviours or exposures meaningfully affect one's own risk of incident SARS-CoV-2 infection. Our objective is to identify individual-level factors associated with one's personal risk of contracting SARS-CoV-2. Design Prospective cohort study of adult participants from 26 March 2020 to 8 October 2020. Setting The COVID-19 Citizen Science Study, an international, community and mobile-based study collecting daily, weekly and monthly surveys in a prospective and time-updated manner. Participants All adult participants over the age of 18 years were eligible for enrolment. Primary outcome measure The primary outcome was incident SARS-CoV-2 infection confirmed via PCR or antigen testing. Results 28 575 unique participants contributed 2 479 149 participant-days of data across 99 different countries. Of these participants without a history of SARS-CoV-2 infection at the time of enrolment, 112 developed an incident infection. Pooled logistic regression models showed that increased age was associated with lower risk (OR 0.98 per year, 95% CI 0.97 to 1.00, p=0.019), whereas increased number of non-household contacts (OR 1.10 per 10 contacts, 95% CI 1.01 to 1.20, p=0.024), attending events of at least 10 people (OR 1.26 per 10 events, 95% CI 1.07 to 1.50, p=0.007) and restaurant visits (OR 1.95 per 10 visits, 95% CI 1.42 to 2.68, p<0.001) were associated with significantly higher risk of incident SARS-CoV-2 infection. Conclusions Our study identified three modifiable health behaviours, namely the number of non-household contacts, attending large gatherings and restaurant visits, which may meaningfully influence individual-level risk of contracting SARS-CoV-2.
Competing interests None declared. Patient consent for publication Not required. Ethics approval The study was approved by the University of California, San Francisco Institutional Review Board (#17-21879). Provenance and peer review Not commissioned; externally peer reviewed. Data availability statement Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplemental information. Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise. Open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited,..
References
Adorni, Prinelli, Bianchi, Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey, JMIR Public Heal Surveill
Avram, Tison, Aschbacher, Real-World heart rate norms in the health eHeart study, NPJ Digit Med, doi:10.1038/s41746-019-0134-9
Bagchi, Mak, Li, Rates of COVID-19 Among Residents and Staff Members in Nursing Homes -United States, May 25, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm7002e2
Barrios, Hochberg, Risk perception through the lens of politics in the time of the COVID-19 pandemic, SSRN Journal, doi:10.2139/ssrn.3568766
Chernozhukov, Kasahara, Schrimpf, Causal impact of masks, policies, behavior on early covid-19 pandemic in the U, S. J Econom
Christensen, Dixit, Dewland, Sleep characteristics that predict atrial fibrillation, Heart Rhythm, doi:10.1016/j.hrthm.2018.05.008
Chu, Akl, Duda, Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis, Lancet, doi:10.1016/S0140-6736(20)31142-9
Cooper, Milic, Mills, Endothelial function: the impact of objective and subjective socioeconomic status on flow-mediated dilation, Ann Behav Med, doi:10.1007/s12160-010-9181-9
Courtemanche, Garuccio, Le, Strong social distancing measures in the United States reduced the COVID-19 growth rate, Health Aff, doi:10.1377/hlthaff.2020.00608
Dixit, Pletcher, Vittinghoff, Secondhand smoke and atrial fibrillation: data from the health eHeart study, Heart Rhythm, doi:10.1016/j.hrthm.2015.08.004
Furukawa, Brooks, Sobel, Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic, Emerg Infect Dis, doi:10.3201/eid2607.201595
Gollwitzer, Martel, Brady, Partisan differences in physical distancing are linked to health outcomes during the COVID-19 pandemic, Nat Hum Behav, doi:10.1038/s41562-020-00977-7
Goodman, Adler, Kawachi, Adolescents' perceptions of social status: development and evaluation of a new indicator, Pediatrics, doi:10.1542/peds.108.2.e31
Greenhalgh, Schmid, Czypionka, Face masks for the public during the covid-19 crisis, BMJ, doi:10.1136/bmj.m1435
Harrison, Fazio-Eynullayeva, Lane, Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis, PLoS Med, doi:10.1371/journal.pmed.1003321
Hsiang, Allen, Annan-Phan, The effect of large-scale anti-contagion policies on the COVID-19 pandemic, Nature, doi:10.1038/s41586-020-2404-8
Kaur, Gupta, COVID-19 vaccine: a comprehensive status report, Virus Res
Lyu, Wehby, Community use of face masks and COVID-19: evidence from a natural experiment of state mandates in the US, Health Aff, doi:10.1377/hlthaff.2020.00818
Menni, Valdes, Freidin, Real-time tracking of self-reported symptoms to predict potential COVID-19, Nat Med, doi:10.1038/s41591-020-0916-2
Mizumoto, Kagaya, Zarebski, Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond Princess cruise SHIP, Eurosurveillance, doi:10.2807/1560-7917.ES.2020.25.10.2000180
Nguyen, Drew, Graham, Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study, Lancet Public Health, doi:10.1016/S2468-2667(20)30164-X
Olgin, Pletcher, Marcus, The health eHeart study
Painter, Qiu, Political beliefs affect compliance with COVID-19 social distancing orders, SSRN Electronic Journal, doi:10.2139/ssrn.3569098
Salmon Ceron, Bartier, Hautefort, Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study, J Infect, doi:10.1016/j.jinf.2020.07.005
Sanyaolu, Okorie, Marinkovic, Comorbidity and its impact on patients with COVID-19, SN Compr. Clin. Med, doi:10.1007/s42399-020-00363-4
Tison, Avram, Kuhar, Worldwide effect of COVID-19 on physical activity: a descriptive study, Ann Intern Med, doi:10.7326/M20-2665
Tromberg, Schwetz, Pérez-Stable, Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States -The NIH RADx Initiative, N Engl J Med, doi:10.1056/NEJMsr2022263
Wang, Li, Liu, An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics, J Infect Public Health, doi:10.1016/j.jiph.2020.07.004
Wang, Olgin, Nah, Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the health eHeart study, PLoS One, doi:10.1371/journal.pone.0198681
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit